{"id":"W1989702104","doi":"10.1016/j.jaad.2011.06.041","title":"Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): Results from analyses of infections and malignancy from pooled phase II and III clinical trials","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":140,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; Dalhousie University; Probity Medical Research","funders":"","keywords":"Ustekinumab; Medicine; Placebo; Psoriasis; Internal medicine; Population; Epidemiology; Confidence interval; Clinical trial; Randomized controlled trial; Dermatology; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01085422,0.001068424,0.003608064,0.0004571566,0.0004942507,0.001918858,0.0006425983,0.001126406,0.00133582],"category_scores_gemma":[0.005917899,0.0005376347,0.004753925,0.000796828,0.0009520475,0.001512165,0.0005330993,0.002603907,0.0003176796],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006566056,"about_ca_system_score_gemma":0.0007806233,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004698763,"about_ca_topic_score_gemma":0.0009973367,"domain_scores_codex":[0.996235,0.002418607,0.0002832039,0.0003508688,0.0004121595,0.000300091],"domain_scores_gemma":[0.9934804,0.002730656,0.002065397,0.0006234369,0.0004712964,0.0006287905],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.6359842,0.003946684,0.07334671,0.003011476,0.05248486,0.000250017,0.0005389834,0.003412995,0.01833391,0.0003791452,0.004647092,0.2036639],"study_design_scores_gemma":[0.24415,0.3252049,0.3442994,0.000641408,0.05847177,0.001761914,0.0004279878,0.002048305,0.008876761,0.001273253,0.01263915,0.0002050348],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9405556,0.05271994,0.001467966,0.0008219682,0.0001780186,0.0003466873,0.001511113,0.0000758646,0.002322712],"genre_scores_gemma":[0.988576,0.007663589,0.0004063548,0.0008600244,0.0003196925,0.0001386724,0.001535151,0.00002435261,0.0004761092],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01085422,"threshold_uncertainty_score":0.05740327,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07938100106568033,"score_gpt":0.367419522118947,"score_spread":0.2880385210532667,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}